good news, page-4

ousia,
what costs do expect to be incurred in the process of listing ACL oncology and realising the 50m.
have you factored or do you expect further dilution and how might this affect the 1000% return. A higher market cap doesn't always come from increased value to existing holders as per current situation.
I'm long ACL but just looking to flesh out the ideas you have put forward.

The cost of realising the 50 m is the main concern I have at the moment. EG. if it costs 10m to list a 400m company then not such a big deal but 10m of 50 obviously is a bigger impact on existing holders.

Just promoting discussion.